Influenza immunization of children with neoplastic diseases. Academic Article Article uri icon

Overview

MeSH

  • Antibodies, Viral
  • Antineoplastic Agents
  • Child
  • Female
  • Fever
  • Humans
  • Immunosuppression
  • Influenza A virus
  • Influenza Vaccines
  • Leukemia
  • Lymphoma
  • Male
  • Time Factors

MeSH Major

  • Influenza, Human
  • Neoplasms
  • Vaccination

abstract

  • During the National Influenza Immunization Program in 1976, 147 children with neoplastic diseases received Wyeth split-product bivalent influenza vaccine: A/New Jersey/8/76 (HSW1N1), A/Victoria/3/75 (H3N2). Thirteen normal siblings served as controls. Seventy-one patients received two doses of the vaccine four weeks apart. After the second injection of A/NJ/8/76, there was a difference between the response of the patients on chemotherapy and those off therapy greater than or equal to 30 days--38% vs. 76%, P less than 0.01 for four-fold rise and 26% vs. 57%, P less than 0.05 for the attainment of protective (greater than or equal to 32) hemagglutination inhibition (HI) titers. These differences were observed in both leukemia-lymphoma and solid tumor patients. There was a difference in HI titers to A/Vic/75 between patients on and off chemotherapy after a single injection, 34% vs. 71%, P less than 0.001 for a four-fold rise. After the second immunization, only 52% on, and 86% off therapy (P less than 0.05) had a four-fold rise in titers. Thirty-two percent of the patients on treatment who achieved "protective" titers did so only after the second immunization. Immunoglobulin levels and neutropenia did not correlate with the inability to obtain a four-fold rise in titers. Our findings suggest that patients on chemotherapy cannot be effectively vaccinated by a new antigen, and that single yearly boosters may be insufficient for recall of old antigens. Patients off chemotherapy greater than or equal to 30 days respond as normal controls.

publication date

  • February 15, 1980

has subject area

  • Antibodies, Viral
  • Antineoplastic Agents
  • Child
  • Female
  • Fever
  • Humans
  • Immunosuppression
  • Influenza A virus
  • Influenza Vaccines
  • Influenza, Human
  • Leukemia
  • Lymphoma
  • Male
  • Neoplasms
  • Time Factors
  • Vaccination

Research

keywords

  • Comparative Study
  • Journal Article

Identity

Language

  • eng

PubMed ID

  • 7357492

Additional Document Info

start page

  • 750

end page

  • 756

volume

  • 45

number

  • 4